Esther A. Torres
About
In The Last Decade
Esther A. Torres
69 papers receiving 563 citations
Peers
Comparison fields: 5 of 76
- Epidemiology 316
- Genetics 170
- Hepatology 153
- Surgery 127
- Public Health, Environmental and Occupational Health 103
Countries citing papers authored by Esther A. Torres
This map shows the geographic impact of Esther A. Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther A. Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther A. Torres more than expected).
Fields of papers citing papers by Esther A. Torres
This network shows the impact of papers produced by Esther A. Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther A. Torres. The network helps show where Esther A. Torres may publish in the future.
Co-authorship network of co-authors of Esther A. Torres
This figure shows the co-authorship network connecting the top 25 collaborators of Esther A. Torres. A scholar is included among the top collaborators of Esther A. Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther A. Torres. Esther A. Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 34 | |
| 8 | 2 | |
| 9 | Liver transplantation for hepatocellular carcinoma in Puerto Ricans: underutilization of a curative therapy. | 4 |
| 10 | Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico. | 3 |
| 11 | 11 | |
| 12 | Outcomes of an underserved Hispanic population with chronic hepatitis C treated with pegylated-interferon and ribavirin in a government-sponsored clinic. | 2 |
| 13 | 14 | |
| 14 | 39 | |
| 15 | 20 | |
| 16 | 12 | |
| 17 | 3 | |
| 18 | 29 | |
| 19 | 4 | |
| 20 | A government sponsored clinic for the evaluation and treatment of chronic hepatitis C in an underinsured population in Puerto Rico. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.